Heart assembloids give researchers a new way to study heart valve disorders
· Medical Xpressedited by Sadie Harley, reviewed by Robert Egan
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
A multidisciplinary, multi-institution group of researchers focused their expertise in genetics, mechanics, chemistry and biology on a chip the size of a postage stamp to model a particular class of heart conditions.
In a first for the field, a team led by Guang Li, an associate professor in the School of Medicine's Department of Cell Biology, has grown heart valves on organoids, miniature, simplified versions of a human heart chamber. The work, published in the journal Cell Stem Cell, is an important step toward better understanding—and treating—a number of serious heart disorders.
This kind of research often depends on animal models, where researchers can study the development of heart valves that grow much faster than those of humans (which take nearly 10 weeks to fully develop) and do not raise the same ethical dilemmas as research in humans.
But Li said, "Human valves are very different from animal valves." Imagine the physiological and genetic differences between a person and, for instance, a zebrafish. "To study human valve diseases, we need human valve models."
Building a more lifelike model
Grown from pluripotent adult human stem cells, organoids offer just such a model. The stem cells can be generated from skin, blood or other cells, then coaxed into developing into cells from a body part of interest—a human heart in this case. Different types of organoids can be combined into "assembloids" to better model complex organs that natively originate from combinations of different tissues.
But a living, functioning heart is more than a cluster of certain types of cells. Its development and continued operation are dependent, among other things, on a complex interaction of different forces. To build analogs of those forces into the model, Li sought the engineering expertise of colleagues, including Lance Davidson, the William Kepler Whiteford Professor of Bioengineering in the Swanson School of Engineering, and Si-Yang Zhen, a professor of biomedical engineering at Carnegie Mellon University.
"This kind of project is really a hallmark of the community of researchers in Pittsburgh," Davidson said.
Forces that shape valve growth
To create a model, Li grew a valve on the surface of a heart assembloid—two organoids made from different types of heart cells that were combined into one platform.
The team was then able to stimulate growth by designing ways to mimic the forces that would act on an embodied heart: a flowing medium to simulate blood, an endothelial culture that simulates cells lining heart valves and even a set of magnetized beads that moved according to the placement of a magnetic belt to simulate muscle contraction.
With the organoid working to simulate a heart with valves, the team now had a model they could use to study four types of valve disorders, including mitral valve prolapse (MVP), a genetic disorder affecting 7 million to 8 million individuals in the U.S. at any given time.
When Li introduced a mutation associated with the disease, the developing valves showed signs of MVP. In other cases, damage was simulated or introduced to mirror the damage that can occur to a person's valves throughout life in conditions such as valve calcification, cryoinjury and complications from hypoglycemia and diabetes.
From disease signals to treatment targets
Li was able to begin studying the organoids, identifying some pathways responsible for the developmental problems associated with MVP and ways they can be corrected. He was also able to develop models for the acquired deficiencies and will go on to look for ways to treat them.
Next, however, Li plans to add complexity to his assembloids, growing them with two chambers and growing the valves inside them, instead of on the surface, to better model a real human heart.
Publication details
Human iPSC-derived heart valve-like assembloids model valve development and disease pathology, Cell Stem Cell (2026). DOI: 10.1016/j.stem.2026.07.011
Journal information: Cell Stem Cell
Key medical concepts
Clinical categories
CardiologyClinical genetics Provided by University of Pittsburgh Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Heart assembloids give researchers a new way to study heart valve disorders (2026, August 11) retrieved 12 August 2026 from https://medicalxpress.com/news/2026-08-heart-assembloids-valve-disorders.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.